Published in PLoS One on September 27, 2016
NCBI GEO: mining tens of millions of expression profiles--database and tools update. Nucleic Acids Res (2006) 19.42
Alzheimer's disease. N Engl J Med (2004) 7.50
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2001) 5.60
Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) (2005) 4.96
Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol (2006) 4.01
Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol (2003) 3.62
A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest (2012) 2.98
The cell biology of leukocyte-mediated proteolysis. J Leukoc Biol (1999) 2.58
Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem (1980) 2.53
Functions of S100 proteins. Curr Mol Med (2013) 2.43
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J (2010) 2.26
Neutral endopeptidase 24.11 (enkephalinase) and related regulators of peptide hormones. FASEB J (1989) 2.24
Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42. J Biol Chem (2006) 2.09
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases. Pharmacol Rev (2010) 1.97
Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A (1997) 1.82
Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci (2006) 1.75
A global meta-analysis of microarray expression data to predict unknown gene functions and estimate the literature-data divide. Bioinformatics (2009) 1.65
Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem (2002) 1.63
Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis. Mol Biosyst (2011) 1.62
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med (2015) 1.61
Cellular signalling of the receptor for advanced glycation end products (RAGE). Cell Signal (2013) 1.48
Proteolytic degradation of amyloid β-protein. Cold Spring Harb Perspect Med (2012) 1.46
Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis (2001) 1.41
Serine proteases. IUBMB Life (2009) 1.39
RAGE: a single receptor fits multiple ligands. Trends Biochem Sci (2011) 1.39
Families and clans of serine peptidases. Arch Biochem Biophys (1995) 1.38
Rapid inactivation of stromal cell-derived factor-1 by cathepsin G associated with lymphocytes. Eur J Immunol (2001) 1.36
Alzheimer's disease and the amyloid-beta peptide. J Alzheimers Dis (2010) 1.33
Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal (2011) 1.29
Structural basis for increased toxicity of pathological aβ42:aβ40 ratios in Alzheimer disease. J Biol Chem (2011) 1.26
RAGE regulation and signaling in inflammation and beyond. J Leukoc Biol (2013) 1.21
Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides (2004) 1.10
Immune privilege of the CNS is not the consequence of limited antigen sampling. Sci Rep (2014) 1.09
Human neutrophil elastase responsive delivery from poly(ethylene glycol) hydrogels. Biomacromolecules (2009) 1.07
Revisiting the Mechanisms of CNS Immune Privilege. Trends Immunol (2015) 1.04
RAGE and amyloid beta interactions: atomic force microscopy and molecular modeling. Biochim Biophys Acta (2005) 1.02
Neutrophil serine proteases: mediators of innate immune responses. Curr Opin Hematol (2011) 1.00
Proteolysis of C3 on U937 cell plasma membranes. Purification of cathepsin G. J Immunol (1991) 0.95
Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases. Growth Horm IGF Res (1999) 0.94
Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol Aging (1997) 0.93
Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. Free Radic Biol Med (2008) 0.93
The antimicrobial heterodimer S100A8/S100A9 (calprotectin) is upregulated by bacterial flagellin in human epidermal keratinocytes. J Invest Dermatol (2010) 0.92
Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Neurobiol Aging (2014) 0.90
Role of Aβ-receptor for advanced glycation endproducts interaction in oxidative stress and cytosolic phospholipase A₂ activation in astrocytes and cerebral endothelial cells. Neuroscience (2011) 0.89
Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system. J Alzheimers Dis (2009) 0.88
Activation of microglia: a neuroinflammatory role for CAP37. Glia (2003) 0.87
Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE. J Immunol (2015) 0.87
Morphometric analysis of the degradation of human skin elastic fibres by human leukocyte elastase (EC 3-4-21-37) and human skin fibroblast elastase (EC 3-4-24). Pathol Biol (Paris) (1988) 0.86
Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9. J Biol Chem (2015) 0.85
Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience (1994) 0.85
Prevention of anti-microbial peptide LL-37-induced apoptosis and ATP release in the urinary bladder by a modified glycosaminoglycan. PLoS One (2013) 0.83
Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease. Acta Neuropathol (2015) 0.82
Cathepsin G, a regulator of human vitamin K, dependent clotting factors and inhibitors. Thromb Res (1992) 0.81
Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor. J Immunol (2014) 0.81
Human neutrophil granule cationic protein CAP37 is a specific macrophage chemotaxin that shares homology with inflammatory proteinases. Adv Exp Med Biol (1991) 0.81
Neutrophil elastase-induced elastin degradation mediates macrophage influx and lung injury in 60% O2-exposed neonatal rats. Am J Physiol Lung Cell Mol Physiol (2015) 0.80
Astrocyte's RAGE: More Than Just a Question of Mood. Cent Nerv Syst Agents Med Chem (2016) 0.78
Neutrophil-derived azurocidin cleaves insulin-like growth factor-binding protein-1, -2 and -4. Growth Horm IGF Res (2011) 0.78
Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease. J Alzheimers Dis (2015) 0.77
The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease. Histochem Cell Biol (2015) 0.77
Specific cleavage of insulin-like growth factor-binding protein-1 by a novel protease activity. Cell Mol Life Sci (2006) 0.77
Reconstitution of human azurocidin catalytic triad and proteolytic activity by site-directed mutagenesis. Biol Chem (2008) 0.76
Autotaxin and Endotoxin-Induced Acute Lung Injury. PLoS One (2015) 0.81